Drug, Device, Digital: Reimagined Healthcare?
Digital solutions are increasingly part of new healthcare standards. However, the solutions available today are very widespread and not readily available to healthcare professionals and their patients. For that reason, the successful adoption of digital health needs better integration across patients and products i.e. the device and the drug. The integration and provision of end-to-end products and services achieves this and facilitates communication to those involved in the continuum of care. This webinar will be of interest to decision makers in digital health within the lifesciences industry.
In this online discussion, you will:
- Understand the benefits of integrated digital health solutions
- Discover the latest trends digital healthcare
- Meet expert Pharma Executives in digital health
Aurore Beaume, Senior Vice President Global Business Development – Voluntis, an Aptar Pharma Company
Céline Ulmann, Head of R&D Digital, Almirall
Stacy Feld, Head J&J Innovation West North America, Australia & New Zealand, Johnson & Johnson
Josh Raysman, Vice President, Digital Innovation Lab, Pfizer